Reddy's (Obeda), Sun Pharma, and other CDSCO-approved manufacturers now offer semaglutide at a fraction of the branded price
Despite the expenses related to the medication, many patients find Semaglutide GLP-1 to be a valuable investment due to its potential to facilitate weight loss comparable to surgical alternatives, which may come with higher costs, considerable downtime, and a higher risk of side effects
Our experienced medical team helps patients lose weight safely and effectively through personalized treatment plans designed to support long-term health and wellness
According to poison control data, from 2019 to 2025, U.S
The 2020 standards go further and recommend CGM as a monitoring option for patients with a history of hypoglycemia and those who havent met glycemic targets with self-monitoring
Miller WC, Koceja DM, Hamilton EJ